VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | The importance of early treatment in MGRS & the role of the MDT

Artur Jurczyszyn, MD, PhD, Jagiellonian University Medical College, Kraków, Poland, comments on the importance of early treatment of patients with monoclonal gammopathy of renal significance (MGRS) with autologous transplantation, highlighting the role of the multidisciplinary team (MDT) in the management of these patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter